Market Place
Sourcing Support
All News #Library
Biotech
Hengrui Pharma, Braveheart Bio Report Positive Phase 2 Results
30 Mar 2026 //
PR NEWSWIRE
Kailera, Hengrui To Advance Oral Obesity Drug Into 2 New Trials
10 Feb 2026 //
FIERCE BIOTECH
Hengrui & Kailera Share Ph3 China Data on Dual GLP-1/GIP Agonist
04 Nov 2025 //
GLOBENEWSWIRE
Hengrui Pharma, Kailera Therapeutics To Present Phase 3 HRS9531
21 Oct 2025 //
GLOBENEWSWIRE
Hengrui Unveils Booth At ESMO Featuring Groundbreaking Data
20 Oct 2025 //
PR NEWSWIRE
Hengrui’s GLP-1/GIP Agonist Reports 18% Weight Loss in Phase 3
16 Jul 2025 //
FIERCE BIOTECH
FDA rejects Hengrui, Elevar`s PD-1 cancer drug combo—again
22 Mar 2025 //
FIERCE PHARMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.